US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist
  • 1.150
  • +0.070+6.48%
Close May 3 16:00 ET
  • 1.140
  • -0.010-0.87%
Post 19:30 ET
193.13MMarket Cap-2017P/E (TTM)

About X4 Pharmaceuticals Company

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Company Profile

SymbolXFOR
Company NameX4 Pharmaceuticals
Listing DateNov 16, 2017
Issue Price10.00
Founded2010
CEODr. Paula S. Ragan, PhD
MarketNASDAQ
Employees93
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address61 North Beacon Street,4th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02134
Phone1-857-529-8300

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paula S. Ragan, PhD
  • Director, President and Chief Executive Officer
  • 2.04M
  • Arthur Taveras
  • Chief Scientific Officer
  • --
  • Adam S. Mostafa
  • Chief Financial Officer, Principal Accounting Officer, Treasurer and Corporate Secretary
  • 1.15M
  • Dr. Mary DiBiase, PhD
  • Chief Operating Officer
  • --
  • Christophe Arbet-Engels
  • Chief Medical Officer
  • 1.64M
  • Mark Baldy
  • Chief Commercial Officer
  • --
  • Michael Stephen Wyzga
  • Chairman of the Board
  • 199.34K
  • Dr. Murray W. Stewart, M.D.
  • Director
  • 90.08K
  • Dr. Gary J. Bridger, PhD
  • Director
  • 147.05K
  • Francoise de Craecker
  • Independent Director
  • 152.05K
  • William E. Aliski
  • Independent Director
  • 165.05K
  • Robert Keith Woods
  • Independent Director
  • 91.83K
  • Alison F. Lawton
  • Independent Director
  • 154.55K
  • David W.J. McGirr, M.B.A.
  • Independent Director
  • 166.05K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg